Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 2
1960 1
1963 1
1964 2
1965 2
1966 3
1967 1
1968 1
1970 1
1977 2
1980 2
1982 5
1986 1
1990 1
1991 1
1994 1
1995 2
1996 2
1997 1
1998 4
1999 3
2000 1
2002 1
2003 1
2004 1
2012 2
2014 1
2015 3
2016 2
2017 2
2018 3
2019 1
2020 4
2021 4
2022 7
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Thompson AJ, et al. Among authors: coetzee t. Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Lancet Neurol. 2018. PMID: 29275977 Review.
Multiple sclerosis progression: time for a new mechanism-driven framework.
Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J, Marrie RA, Montalban X, Yong VW, Thompson AJ, Reich DS; International Advisory Committee on Clinical Trials in Multiple Sclerosis. Kuhlmann T, et al. Among authors: coetzee t. Lancet Neurol. 2023 Jan;22(1):78-88. doi: 10.1016/S1474-4422(22)00289-7. Epub 2022 Nov 18. Lancet Neurol. 2023. PMID: 36410373 Review.
Introducing the Barancik Prize lecture series.
Coetzee T, Bebo B. Coetzee T, et al. Mult Scler. 2019 Dec;25(14):1826-1827. doi: 10.1177/1352458519887342. Epub 2019 Nov 5. Mult Scler. 2019. PMID: 31687880 Free PMC article. No abstract available.
Atlas of MS 2020: Informing global policy change.
Coetzee T, Thompson AJ. Coetzee T, et al. Mult Scler. 2020 Dec;26(14):1807-1808. doi: 10.1177/1352458520968811. Epub 2020 Nov 11. Mult Scler. 2020. PMID: 33174499 No abstract available.
The 2013 clinical course descriptors for multiple sclerosis: A clarification.
Lublin FD, Coetzee T, Cohen JA, Marrie RA, Thompson AJ; International Advisory Committee on Clinical Trials in MS. Lublin FD, et al. Among authors: coetzee t. Neurology. 2020 Jun 16;94(24):1088-1092. doi: 10.1212/WNL.0000000000009636. Epub 2020 May 29. Neurology. 2020. PMID: 32471886 Free PMC article. Review.
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal.
Thompson AJ, Carroll W, Ciccarelli O, Comi G, Cross A, Donnelly A, Feinstein A, Fox RJ, Helme A, Hohlfeld R, Hyde R, Kanellis P, Landsman D, Lubetzki C, Marrie RA, Morahan J, Montalban X, Musch B, Rawlings S, Salvetti M, Sellebjerg F, Sincock C, Smith KE, Strum J, Zaratin P, Coetzee T. Thompson AJ, et al. Among authors: coetzee t. Mult Scler. 2022 Jan;28(1):16-28. doi: 10.1177/13524585211059766. Epub 2021 Dec 1. Mult Scler. 2022. PMID: 34850641 Free PMC article. Review.
Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposal.
Dangond F, Donnelly A, Hohlfeld R, Lubetzki C, Kohlhaas S, Leocani L, Ciccarelli O, Stankoff B, Sormani MP, Chataway J, Bozzoli F, Cucca F, Melton L, Coetzee T, Salvetti M. Dangond F, et al. Among authors: coetzee t. Nat Rev Neurol. 2021 Mar;17(3):185-192. doi: 10.1038/s41582-020-00446-9. Epub 2021 Jan 22. Nat Rev Neurol. 2021. PMID: 33483719 Review.
72 results